Czech Republic - Mechanotherapy devices - Therapeutic platform II.
€16,734
Award value
67% under estimate
27 contracts won, worth €12.2M, from 15 public buyers.
Main sectors Medical equipment & pharmaceuticals 26, Laboratory & precision equipment 1
We email you when this company wins a new contract. Free, one click to stop.
Record
Each dot is one award, placed on its date and sized by its value.
Relations
Shares of the 27 contracts this company has won.
Radar
Contracts this company holds that end within the next two years. The specification for the replacement is usually shaped 18 to 26 months before the notice appears.
€127,479 current contract
this month
Oct 2026
€16,734 current contract
1 month
Nov 2026
€237,988 current contract
2 months
Dec 2026
€2.1M current contract
5 months
Mar 2027
€145,661 current contract
20 months
Jun 2028
€175,920 current contract
22 months
Jul 2028
€196,281 current contract
22 months
Jul 2028
€76,550 current contract
22 months
Jul 2028
€35,062 current contract
22 months
Jul 2028
€86,157 current contract
22 months
Jul 2028
Prices
€147,645
over 27 awards with a published amount
At estimate
typical award, over 24 contracts with both figures
27 months
median, over 20 contracts with a known length
Territory
Shares of the 27 contracts that name a region.
Register
Each bar compares an award with the largest on this page, €2.3M.
€16,734
Award value
67% under estimate
€237,988
Award value
13% over estimate
€110,343
Award value
€2.1M
Award value
€127,479
Award value
€2.3M
Award value
5.2% over estimate
€2.2M
Award value
at estimate
€129,695
Award value
1.9% over estimate
€170,599
Award value
at estimate
€72,107
Award value
50% under estimate
€111,157
Award value
at estimate
€107,653
Award value
4.2% over estimate
€175,920
Award value
6.4% over estimate
€196,281
Award value
3.1% under estimate
€76,550
Award value
2.5% under estimate
€35,062
Award value
at estimate
€86,157
Award value
40% under estimate
€202,417
Award value
at estimate
€145,661
Award value
43% under estimate
€361,366
Award value
9.3% over estimate